Jazz Pharmaceuticals PLC at Evercore ISI HealthCONx Conference (Virtual) Transcript
Before we begin, I thought it might be a great idea to turn it over to Bruce first to kick things off, and we'll jump right into it.
Awesome, Umer. Thanks for the invitation, and I'll keep my opening remarks mercifully brief and I'm happy to jump into Q&A.
So as a reminder, before I make any substantive comments, I will use some forward-looking statements today. See the risk factors in our SEC filings. I'll also refer to non-GAAP financial measures. We provide a full reconciliation to GAAP on our website. And if I refer to guidance today, it's guidance as we gave it on November 9.
So we reported third quarter results earlier this month, and we were really pleased with the strong performance across all areas of our business leading to significant top line and bottom line growth. You'll all have seen that we raised the midpoint of our full year
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |